Oncology One is pleased to share a poster presented by Pfizer Inc. at the American Association for Cancer Research (AACR) Annual Meeting 2021.
The poster comprises data from our research collaboration with Pfizer and local medical research institutions, Walter and Eliza Hall Institute of Medical Research and Peter MacCallum Cancer Centre, and the Cancer Therapeutics (CTx CRC Limited).
“It was fantastic to be involved in this collaboration, a great example of how industry and academia can work together to answer challenging questions and drive forward the development of a new therapeutic class,” said Oncology One Chair of the Scientific Advisory Board, Dr Ian Street.
The collaboration involved the Thomas/Voss (MYST biology), Visvader/Lindeman (Breast Cancer), the Davis (Computational Biology), and the Groome (Immunology) laboratories from WEHI;
and the Sarah-Jane and Mark Dawson (breast cancer and epigenetic mechanism) laboratory from the Peter Mac.
The Australian team worked with the scientists from the Pfizer Tumour Biology, Division, based in La Jolla, California to unravel some of the mechanistic aspects of KAT6 tumour biology.